Venture Capital

E-commerce logistics firm Globavend Holdings raised $1.4M in a direct offering, but its stock tumbled. A look at the deal, the market, and what's next.

Sony Honda Mobility's high-tech AFEELA 1 EV has started trial runs in Ohio, introducing a unique 'Quality Gate' to ensure its advanced tech is flawless.

Quectel's new AR588MA is the first automotive module with 3GPP R18 5G-Advanced, promising a leap in autonomous driving and connected car reliability.

Entertainment giant Banijay divests its majority stake in bet-at-home to fund a landmark merger with Tipico, reshaping its gaming strategy and the market.

Tesla's Q4 report shows a complex picture. Vehicle deliveries fell short, but record-breaking growth in the energy division hints at a major strategic shift.

In a strategic move beyond typical endorsements, Fabletics partners with NFL star Ja’Marr Chase on a co-created collection to disrupt the men's market.

China's JIADE LIMITED partners with South Korea's Chinalink, leveraging AI to expand education services to North America, Asia, and the Middle East.

With a new growth chief and key cloud partnerships, Atropos Health is aggressively moving to make its AI the new standard for real-world evidence in medicine.

Nexxen doubles down on shareholder returns with a new $40M buyback, signaling deep confidence amid market volatility and a strategic push into CTV.

With a blockbuster 2025 in the books, Boston Scientific's leadership faces intense scrutiny at upcoming investor events to prove its growth is sustainable.

BridgeBio Pharma hosts a key investor webinar on its oral drug infigratinib for achondroplasia, setting the stage for crucial trial results in Q1 2026.

Bitcoin miner Bitfarms sells its last Latin American asset for $30M, pivoting fully to the booming North American AI and HPC infrastructure market.

Innocan Pharma is set to debut on the NYSE American, aiming to boost its innovative CBD drug delivery platform for non-opioid pain relief. What's next?

Singapore's Flint begins manufacturing its eco-friendly paper batteries, partnering with Logitech and Amazon to disrupt the global battery supply chain.

Neovii Pharmaceuticals names Frédéric Prince its next CEO, bringing deep oncology and gene therapy experience from Roche to steer its next growth phase.

CACI International has won a landmark contract to overhaul U.S. Space Force networks, deploying advanced software-defined tech to counter growing threats.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

NAVER D2SF invests in Sorcerics, a startup whose proactive AI and on-device processing promise a smarter, safer, and more affordable smart home future.

AI drug discovery firm Insilico Medicine soars in its Hong Kong debut, the city's largest biotech IPO of 2025, validating a new tech-driven era for medicine.

Despite falling revenue and supply chain chaos, CanadaBis posts positive cash flow, signaling a disciplined new strategy for survival and sustainability.